PROM1 and glioma: Approximately 100 CD133+ glioma cells were shown to be sufficient in a groundbreaking work to create xenografted tumors that accurately reflected the heterogeneity of the original tumor, while CD133- cells were efficiently depleted of their ability to cause tumors.